Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 4
1995 2
1996 1
2001 1
2002 2
2003 4
2004 7
2005 7
2006 7
2007 6
2008 3
2009 6
2010 5
2011 5
2012 6
2013 1
2014 2
2015 2
2016 2
2017 1
2018 2
2019 1
2020 1
2021 2
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity.
Baumgartner CK, Ebrahimi-Nik H, Iracheta-Vellve A, Hamel KM, Olander KE, Davis TGR, McGuire KA, Halvorsen GT, Avila OI, Patel CH, Kim SY, Kammula AV, Muscato AJ, Halliwill K, Geda P, Klinge KL, Xiong Z, Duggan R, Mu L, Yeary MD, Patti JC, Balon TM, Mathew R, Backus C, Kennedy DE, Chen A, Longenecker K, Klahn JT, Hrusch CL, Krishnan N, Hutchins CW, Dunning JP, Bulic M, Tiwari P, Colvin KJ, Chuong CL, Kohnle IC, Rees MG, Boghossian A, Ronan M, Roth JA, Wu MJ, Suermondt JSMT, Knudsen NH, Cheruiyot CK, Sen DR, Griffin GK, Golub TR, El-Bardeesy N, Decker JH, Yang Y, Guffroy M, Fossey S, Trusk P, Sun IM, Liu Y, Qiu W, Sun Q, Paddock MN, Farney EP, Matulenko MA, Beauregard C, Frost JM, Yates KB, Kym PR, Manguso RT. Baumgartner CK, et al. Among authors: kym pr. Nature. 2023 Oct;622(7984):850-862. doi: 10.1038/s41586-023-06575-7. Epub 2023 Oct 4. Nature. 2023. PMID: 37794185 Free PMC article.
Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease.
Rosebraugh M, Voight EA, Moussa EM, Jameel F, Lou X, Zhang GGZ, Mayer PT, Stolarik D, Carr RA, Enright BP, Liu W, Facheris MF, Kym PR. Rosebraugh M, et al. Among authors: kym pr. Ann Neurol. 2021 Jul;90(1):52-61. doi: 10.1002/ana.26073. Epub 2021 May 4. Ann Neurol. 2021. PMID: 33772855 Free PMC article.
Analgesic potential of TRPV3 antagonists.
Reilly RM, Kym PR. Reilly RM, et al. Among authors: kym pr. Curr Top Med Chem. 2011;11(17):2210-5. doi: 10.2174/156802611796904889. Curr Top Med Chem. 2011. PMID: 21671874 Review.
Targeting TRP channels for pain relief.
Brederson JD, Kym PR, Szallasi A. Brederson JD, et al. Among authors: kym pr. Eur J Pharmacol. 2013 Sep 15;716(1-3):61-76. doi: 10.1016/j.ejphar.2013.03.003. Epub 2013 Mar 14. Eur J Pharmacol. 2013. PMID: 23500195 Review.
TRPA1: the species difference.
Chen J, Kym PR. Chen J, et al. Among authors: kym pr. J Gen Physiol. 2009 Jun;133(6):623-5. doi: 10.1085/jgp.200910246. J Gen Physiol. 2009. PMID: 19468076 Free PMC article. No abstract available.
Fueling the Pipeline via Innovations in Organic Synthesis.
Voight EA, Greszler SN, Kym PR. Voight EA, et al. Among authors: kym pr. ACS Med Chem Lett. 2021 Aug 27;12(9):1365-1373. doi: 10.1021/acsmedchemlett.1c00351. eCollection 2021 Sep 9. ACS Med Chem Lett. 2021. PMID: 34531945 Free PMC article.
78 results